A drug–drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies

1. de Jong, J.
2. Hellemans, P.
3. De Wilde, S.
4. Patricia, D.
5. Masterson, T.
6. Manikhas, G.
7. Myasnikov, A.
8. Osmanov, D.
9. Córdoba, R.
10. Panizo, C.
11. de Zwart, L.
12. Snoeys, J.
13. Chauhan, V.
14. Jiao, J.
15. Sukbuntherng, J.
16. Ouellet, D.